Skip to main content

Syndicate contentVanderbilt University Medical Center

Vanderbilt scientists report first effective medical therapy for rare stomach disorder

A drug used to treat colorectal cancer also can reverse a rare stomach disorder and should be considered first-line therapy for the disease, researchers at Vanderbilt University Medical Center report this week.

Gene mingling increases sudden death risk

A multi-national research team has discovered that two genetic factors converge to increase the risk of sudden cardiac death.

Hello wearable kidney, goodbye dialysis machine

Researchers are developing a Wearable Artificial Kidney for dialysis patients, reports an upcoming paper in the Clinical Journal of the American Society of Nephrology (CJASN).

Vanderbilt researchers pioneer an advanced sepsis detection and management system

When Jason Martin gives a talk about his research, he begins with the dramatic story of Mariana Bridi da Costa: The young Brazilian supermodel died from severe sepsis in January after amputation of both her hands and feet failed to stop its spread.

TB vaccine gets its groove back

A team of Vanderbilt University Medical Center investigators has cracked one of clinical medicine's enduring mysteries ? what happened to the tuberculosis vaccine.

Licorice compound offers new cancer prevention strategy

A chemical component of licorice may offer a new approach to preventing colorectal cancer without the adverse side effects of other preventive therapies, Vanderbilt University Medical Center researchers report.

Marijuana use could cause tubal pregnancies

Marijuana use may increase the risk of ectopic (tubal) pregnancies, researchers at Vanderbilt University Medical Center reported this week. The researchers studied CB1, a ''cannabinoid'' receptor that binds the main active chemical for marijuana, delta-9-tetrahydrocannabinol (THC). In pregnant mice that lacked the gene for the receptor, or in which the receptor was blocked, the embryo failed to go through the oviduct -- the tube leading from the ovaries to the uterus. The same thing happened in normal mice when the receptor was over-stimulated.

Radioactive microspheres help knock out liver tumors

For once, clogged arteries are a good thing.Physicians treating deadly liver tumors are finding success by injecting patients with radioactive microspheres that get trapped in the web of small blood vessels feeding a tumor and zap the cancerous cells. "The liver doesn't tolerate external beam radiation in sufficient doses to affect tumor without damaging the remaining good liver," said one physician researcher working on the treatment. "These spheres emit radiation for a short distance, less than a centimeter. If you can cluster radiation right around the tumor, the radiation exposure at the tumor site compared to normal liver is favorable."



About us

Science Blog was started in August 2002. It lives, breathes and eats press releases from research organizations around the globe. Most of what you read here are press releases from the outfits named in the stories themselves. Got a news story you think belongs here? Let's talk. The other half of the equation is blog posts from readers like you. So if you have an interest in science, please register and join others like you in an ongoing, vibrant dialog about what makes the world tick. Meantime, please take a minute to read our Privacy Policy and Site Disclaimer.


Premium Drupal Themes by Adaptivethemes